scispace - formally typeset
C

Carlo M. Croce

Researcher at Ohio State University

Publications -  1156
Citations -  199822

Carlo M. Croce is an academic researcher from Ohio State University. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 198, co-authored 1135 publications receiving 189007 citations. Previous affiliations of Carlo M. Croce include University of Nebraska Medical Center & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.

TL;DR: The results suggest that periostin overexpression might be a potential marker for early cancer detection in a specific subset of hereditary breast carcinomas triggered by cancer-associated BRCA1 mutations that affect the BRCT tandem domain.
Journal ArticleDOI

Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner

TL;DR: An expression profiling approach provides evidence that the CDK inhibitor p27Kip1 regulates miRs expression following cell cycle exit following contact inhibition, and proposes a new role for miR-223 in the regulation of breast cancer progression.
Journal ArticleDOI

MicroRNAs in Skeletal Muscle and Hints on Their Potential Role in Muscle Wasting During Cancer Cachexia.

TL;DR: The most recent findings concerning the role of microRNAs in triggering or exacerbating muscle wasting in cancer cachexia are discussed, while mentioning about possible roles played by long non-coding RNAs and ADAR-mediated miRNA modifications.
Journal ArticleDOI

Human HMGA2 protein overexpressed in mice induces precursor T-cell lymphoblastic leukemia.

TL;DR: HMGA2-driven leukemia in mice closely resembles spontaneous human T-ALL, indicating that HMGA2 transgenic mice should serve as an important model for investigating basic mechanisms and potential new therapies of relevance to human T -ALL.
Journal ArticleDOI

Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses.

TL;DR: In vitro analyses and in vivo tumorigenicity studies show that restoration of Fhit protein induces tumor suppression in 50% of tumor cell lines tested, and viral vector-mediated FHIT gene transfer to Fhit-deficient mice not only prevents but reverses the carcinogen-induced tumor development in vivo, in accordance with the oncosuppressive properties of F hit protein.